Similar articles

• The success and failure of BCG - implications for a novel tuberculosis vaccine.

  Andersen P, Doherty TM. Andersen P, et al. Nat Rev Microbiol. 2005 Aug;3(8):656-62. doi: 10.1038/nrmicro1211. Nat Rev Microbiol. 2005. PMID: 16012514 Review.
• [Analysis of the adverse effects occuring after the administration of BCG by oral route in 5,579 healthy children].

  Amato Neto V, de Oliveira e Silva YK, Finger H, Bianchi A, do Amaral JP, Cardozo BS, de Lima Filho MT, Netto NV. Amato Neto V, et al. Rev Paul Med. 1973 Sep-Oct;82(3):135-8. Rev Paul Med. 1973. PMID: 4600148 Clinical Trial. Portuguese. No abstract available.
• Comparative trials of British BCG vaccine double strength, and Danish BCG vaccine, with standard strength British BCG vaccine.

  Galbraith NS, Hall CJ. Galbraith NS, et al. Tubercle. 1974 Dec;55(4):283-9. doi: 10.1016/0041-3879(74)90037-3. Tubercle. 1974. PMID: 4220082 Clinical Trial. No abstract available.
• Evaluation of the effectiveness of BCG vaccination using the case control method.

  Miceli I, Colaiacovo D, Kantor IN, Peluffo G. Miceli I, et al. Dev Biol Stand. 1986;58 ( Pt A):293-6. Dev Biol Stand. 1986. PMID: 3297868 Clinical Trial. No abstract available.
• [Novel vaccines against M. tuberculosis].

  Okada M. Okada M. Kekkaku. 2006 Dec;81(12):745-51. Kekkaku. 2006. PMID: 17240920 Review. Japanese.